Teprotumumab Treatment for Thyroid Eye Disease in a Patient with Pre-Existing Hearing Loss: Worth the Risk?

Wyatt Hyke; Cheryl Polinsky; Lisa Schifanella

doi:10.57204/001c.158919

Loading [Contrib]/a11y/accessibility-menu.js

Hyke W, Polinsky C, Schifanella L. Teprotumumab Treatment for Thyroid Eye Disease in a Patient with Pre-Existing Hearing Loss: Worth the Risk? CRO Journal. Published online September 1, 2026. doi:10.57204/001c.158919

View more stats